How SH2B1 brain circuits control body weight and metabolism

Role of hypothalamic SH2B1 neurocircuits and SH2B1 signal transduction pathways in obesity and metabolic disease

NIH-funded research University of Michigan at Ann Arbor · NIH-11238986

This project looks at whether brain cells that use the protein SH2B1 help control appetite, weight, and blood sugar in people with or at risk for type 2 diabetes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor NIH-funded
Lab location1 site (Ann Arbor, United States)
Project IDNIH-11238986 on NIH RePORTER

What this research studies

Researchers will map and manipulate neurons in a hypothalamic region called the paraventricular hypothalamus (PVH) that express the protein SH2B1 to see how they connect with the dorsal raphe nucleus (DRN) and influence eating and metabolism. They will use genetic approaches to turn SH2B1 on or off in specific neurons and use light-based stimulation to activate PVH→DRN fibers in animal models while measuring food intake, body weight, and blood sugar. The team will study SH2B1 signal-transduction pathways and responses to molecules like BDNF to understand how these signals control energy balance. The goal is to identify specific circuits and signals that could become targets for future treatments for obesity and type 2 diabetes.

Who could benefit from this research

Good fit: Adults with obesity and type 2 diabetes or people at high risk for adult-onset diabetes would be the eventual patient groups most likely to benefit from findings.

Not a fit: People without obesity or type 2 diabetes, or those needing immediate clinical treatment, are unlikely to receive direct benefit from this basic laboratory research.

Why it matters

Potential benefit: If successful, the work could point to new brain-circuit or molecular targets for therapies that reduce appetite, lower body weight, and improve blood sugar control.

How similar studies have performed: Prior mouse studies showed that loss of SH2B1 causes obesity and diabetes and that restoring SH2B1 in neurons reverses the phenotype, and optogenetic activation of PVH fibers reduced food intake, but human translation remains limited.

Where this research is happening

Ann Arbor, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Adult-Onset Diabetes Mellitus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.